Skip to main content
. 2016 Nov 3;14:310. doi: 10.1186/s12967-016-1048-9

Table 2.

Baseline demographics, duration of disease and therapy

UC N = 41 Non UC N = 30
Age (years)
 Mean (SD) 39.3 (18.8) 28.9 (11.0)
 Range 24–60 21–62
Gender, male, n (%) 21 (50) 7 (25)
Duration of UC (years)
 Mean (SD) 11.42 (9.43)
 Range 1–37
Treatment (current)
 TNFα-blocker 21
 Glucocorticoids 11
 Mesalazine 24
 Immuno-suppressive 7
 No 4